Mark For: VEGZELMA® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79294361 |
Registration Number | 6297705 |
Mark Literal Elements | VEGZELMA |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2021-03-23 |
Basis | 66(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | Yes |
Current Basis | No |
No Basis | No |
2020-08-13 | Application Filed |
2020-09-24 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2020-09-24 | Status: Live/Pending |
2020-09-28 | Transaction Date |
2021-01-05 | Published |
2021-03-23 | Location: PUBLICATION AND ISSUE SECTION |
2021-03-23 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
2021-03-23 | Trademark Registered |
2026-03-23 | Maintenance Early File Date |
2027-03-23 | Maintenance On Time Date |
2027-09-23 | Maintenance Late Fee Date |
Party: | ![]() |
Address | 23, Academy-ro, Yeonsu-gu Incheon 22014 KOREA, REPUBLIC OF |
Legal Entity Type | Corporation |
Legal Entity State | KOREA, REPUBLIC OF |
![]() | MULTI | 2020-09-24 |
![]() | JPEG | 2020-09-24 |
![]() | APPLICATION/XML | 2020-10-02 |
![]() | XML | 2020-10-27 |
![]() | XML | 2020-10-27 |
![]() | XML | 2020-11-17 |
![]() | MULTI | 2020-11-24 |
![]() | XML | 2020-11-24 |
![]() | MULTI | 2020-11-26 |
![]() | MULTI | 2020-12-02 |
![]() | XML | 2020-12-03 |
![]() | XML | 2020-12-03 |
![]() | XML | 2020-12-16 |
![]() | XML | 2020-12-16 |
![]() | XML | 2020-12-23 |
![]() | XML | 2021-01-05 |
![]() | XML | 2021-01-07 |
![]() | 2021-03-23 | |
![]() | XML | 2021-06-30 |
![]() | XML | 2021-07-15 |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of cancer; antibodies for medical purposes for the treatment of cancer
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for the treatment of cancer; antibodies for medical purposes |
GS0051 | Pharmaceutical preparations for the treatment of cancer; antibodies for medical purposes for the treatment of cancer |
Description | Date | Proceeding Number |
---|---|---|
FINAL DECISION TRANSACTION PROCESSED BY IB | 2021-07-19 | |
FINAL DISPOSITION PROCESSED | 2021-06-30 | 68359 |
FINAL DISPOSITION NOTICE SENT TO IB | 2021-06-30 | |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2021-06-23 | |
REGISTERED-PRINCIPAL REGISTER | 2021-03-23 | |
NOTIFICATION PROCESSED BY IB | 2021-01-11 | |
PUBLISHED FOR OPPOSITION | 2021-01-05 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-01-05 | |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-12-23 | |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2020-12-23 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-12-16 | |
REFUSAL PROCESSED BY IB | 2020-12-06 | |
NEW REPRESENTATIVE AT IB RECEIVED | 2020-12-04 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-12-01 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-11-25 | 88889 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-11-24 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-11-24 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-11-24 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-11-24 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-11-24 | 88889 |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-11-24 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-11-24 | 88888 |
REFUSAL PROCESSED BY MPU | 2020-11-17 | 70029 |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-11-17 | |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-10-28 | |
NON-FINAL ACTION WRITTEN | 2020-10-27 | 82105 |
ASSIGNED TO EXAMINER | 2020-10-20 | 82105 |
APPLICATION FILING RECEIPT MAILED | 2020-10-02 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-09-28 | |
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-09-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.